Iron behaving badly: inappropriate iron chelation as a major contributor to the aetiology of vascular and other progressive inflammatory and degenerative diseases

по Kell, Douglas B
Опубликовано 2009

Towards a unifying, systems biology understanding of large-scale cellular death and destruction caused by poorly liganded iron: Parkinson’s, Huntington’s, Alzheimer’s, prions, bact...

по Kell, Douglas B.
Опубликовано 2010

Breeding crop plants with deep roots: their role in sustainable carbon, nutrient and water sequestration

по Kell, Douglas B.
Опубликовано 2011

Large-scale sequestration of atmospheric carbon via plant roots in natural and agricultural ecosystems: why and how

по Kell, Douglas B.
Опубликовано 2012

Scientific discovery as a combinatorial optimisation problem: How best to navigate the landscape of possible experiments?

по Kell, Douglas B
Опубликовано 2012

Evolutionary algorithms and synthetic biology for directed evolution: commentary on “on the mapping of genotype to phenotype in evolutionary algorithms” by Peter A. Whigham, Grant...

по Kell, Douglas B.
Опубликовано в: Genet Program Evolvable Mach (2017)

Dormancy in Stationary-Phase Cultures of Micrococcus luteus: Flow Cytometric Analysis of Starvation and Resuscitation

по Kaprelyants, Arseny S., Kell, Douglas B.
Опубликовано 1993

Metabolomics and systems pharmacology: why and how to model the human metabolic network for drug discovery()

по Kell, Douglas B., Goodacre, Royston
Опубликовано 2014

Commentary on “Rapid identification of Streptococcus and Enterococcus species using diffuse reflectance-absorbance Fourier transform infrared spectroscopy and artificial neural net...

по Goodacre, Royston, Kell, Douglas B.
Опубликовано в: FEMS Microbiol Lett (2017)

Corrigendum to “Metabolomics and systems pharmacology: why and how to model the human metabolic network for drug discovery” [Drug Discov. Today 19 (2014), 171–182()

по Kell, Douglas B, Goodacre, Royston
Опубликовано в: Drug Discov Today (2014)

No effects without causes: the Iron Dysregulation and Dormant Microbes hypothesis for chronic, inflammatory diseases

по Kell, Douglas B., Pretorius, Etheresia
Опубликовано в: Biol Rev Camb Philos Soc (2018)

To What Extent Are the Terminal Stages of Sepsis, Septic Shock, Systemic Inflammatory Response Syndrome, and Multiple Organ Dysfunction Syndrome Actually Driven by a Prion/Amyloid...

по Kell, Douglas B., Pretorius, Etheresia
Опубликовано в: Semin Thromb Hemost (2018)

Comparative Genomic Assessment of Novel Broad-Spectrum Targets for Antibacterial Drugs

по White, Thomas A., Kell, Douglas B.
Опубликовано 2004

How drugs get into cells: tested and testable predictions to help discriminate between transporter-mediated uptake and lipoidal bilayer diffusion

по Kell, Douglas B., Oliver, Stephen G.
Опубликовано 2014

The virtue of innovation: innovation through the lenses of biological evolution

по Kell, Douglas B., Lurie-Luke, Elena
Опубликовано в: J R Soc Interface (2015)

Understanding the foundations of the structural similarities between marketed drugs and endogenous human metabolites

по O'Hagan, Steve, Kell, Douglas B.
Опубликовано в: Front Pharmacol (2015)

The apparent permeabilities of Caco-2 cells to marketed drugs: magnitude, and independence from both biophysical properties and endogenite similarities

по O’Hagan, Steve, Kell, Douglas B.
Опубликовано в: PeerJ (2015)

MetMaxStruct: A Tversky-Similarity-Based Strategy for Analysing the (Sub)Structural Similarities of Drugs and Endogenous Metabolites

по O'Hagan, Steve, Kell, Douglas B.
Опубликовано в: Front Pharmacol (2016)

The metabolome 18 years on: a concept comes of age

по Kell, Douglas B., Oliver, Stephen G.
Опубликовано в: Metabolomics (2016)

A Dormant Microbial Component in the Development of Preeclampsia

по Kell, Douglas B., Kenny, Louise C.
Опубликовано в: Front Med (Lausanne) (2016)